25-Patent Vault Locked and Ready for Rescheduling Shift
The regulatory framework for cannabinoid research in the United States is rapidly evolving. A highly anticipated DEA administrative hearing scheduled to begin on June 29, 2026, will evaluate the proposed transition of marijuana from Schedule I to Schedule III. According to official federal notices published by the U.S. Department of Justice, this upcoming proceeding provides a legally compliant pathway to evaluate broader changes to marijuana's status under federal law (Source). For biotechnology entities quietly constructing intellectual property (IP) portfolios around ...